HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Albert Schömig Selected Research
Albert Schömig Research Topics
Disease
114
Myocardial Infarction
05/2015 - 01/2002
64
Coronary Artery Disease (Coronary Atherosclerosis)
11/2013 - 06/2002
55
Thrombosis (Thrombus)
05/2015 - 06/2002
25
Hemorrhage
05/2015 - 01/2004
25
ST Elevation Myocardial Infarction
02/2014 - 06/2005
21
Acute Coronary Syndrome
01/2013 - 05/2004
21
Cardiovascular Diseases (Cardiovascular Disease)
01/2013 - 09/2002
20
Infarction (Infarctions)
03/2013 - 06/2002
15
Pathologic Constriction (Stenosis)
03/2012 - 06/2003
11
Unstable Angina
01/2013 - 09/2003
10
Inflammation (Inflammations)
12/2011 - 06/2003
9
Diabetes Mellitus
11/2013 - 08/2005
9
Stable Angina
03/2013 - 06/2003
8
Coronary Disease (Coronary Heart Disease)
01/2013 - 12/2004
8
Atherosclerosis
12/2011 - 01/2003
8
Neointima
02/2008 - 01/2000
6
Non-ST Elevated Myocardial Infarction
08/2013 - 04/2009
6
Hyperplasia
03/2013 - 01/2003
6
Coronary Restenosis
06/2010 - 12/2005
5
Stroke (Strokes)
05/2015 - 02/2004
4
Death (Near-Death Experience)
06/2013 - 10/2009
4
Type 2 Diabetes Mellitus (MODY)
02/2013 - 11/2006
4
Atherosclerotic Plaque (Atheroma)
07/2012 - 04/2005
4
Body Weight (Weight, Body)
01/2010 - 05/2003
4
Neoplasms (Cancer)
11/2009 - 01/2003
4
Ischemia
01/2008 - 06/2003
3
Cicatrix (Scar)
02/2014 - 04/2004
3
Cardiogenic Shock
07/2012 - 04/2007
3
Coronary Stenosis (Coronary Artery Stenosis)
07/2012 - 04/2008
3
Myocardial Ischemia (Ischemic Heart Diseases)
07/2012 - 01/2008
3
Vascular Remodeling
03/2011 - 08/2005
3
Tachycardia (Tachyarrhythmias)
10/2010 - 12/2003
3
Renal Insufficiency (Renal Failure)
04/2008 - 10/2004
3
Rupture
02/2008 - 04/2005
3
Vascular System Injuries
02/2008 - 08/2004
2
Left Ventricular Dysfunction
09/2015 - 07/2008
2
Heart Failure
07/2012 - 07/2008
2
Hypertension (High Blood Pressure)
08/2011 - 01/2002
2
No-Reflow Phenomenon
05/2010 - 02/2010
2
Necrosis
02/2009 - 04/2008
Drug/Important Bio-Agent (IBA)
34
Clopidogrel (Plavix)
FDA Link
05/2015 - 04/2002
27
Sirolimus (Rapamycin)
FDA Link
11/2013 - 04/2004
23
Abciximab (ReoPro)
FDA Link
08/2013 - 03/2002
13
Paclitaxel (Taxol)
FDA Link
Generic
06/2013 - 08/2005
11
bivalirudin (Angiomax)
FDA Link
08/2013 - 08/2008
11
Glycoproteins (Glycoprotein)
IBA
10/2012 - 03/2002
10
Heparin (Liquaemin)
FDA Link
Generic
08/2013 - 04/2006
9
Biomarkers (Surrogate Marker)
IBA
03/2013 - 02/2005
9
Metals
IBA
09/2011 - 04/2005
9
Troponin T (Troponin T1)
IBA
09/2011 - 05/2003
9
C-Reactive Protein
IBA
01/2011 - 06/2003
8
omega-Chloroacetophenone (Mace)
IBA
01/2013 - 10/2004
7
Troponin
IBA
10/2011 - 03/2008
6
Polymers
IBA
06/2013 - 04/2009
6
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
03/2013 - 10/2005
6
Brain Natriuretic Peptide (Natrecor)
FDA Link
01/2011 - 03/2005
6
Thromboplastin (Tissue Factor)
IBA
07/2009 - 01/2002
5
Gadolinium
IBA
02/2014 - 05/2009
5
Everolimus
FDA Link
11/2013 - 02/2008
5
pro-brain natriuretic peptide (1-76)
IBA
10/2011 - 10/2005
5
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
02/2011 - 03/2006
4
Uric Acid (Urate)
IBA
03/2013 - 05/2012
4
Calcium
IBA
07/2012 - 06/2010
4
Natriuretic Peptides
IBA
10/2011 - 04/2006
4
Trinitrotoluene (TNT)
IBA
10/2011 - 03/2008
4
Homocysteine
IBA
01/2008 - 12/2003
3
Cytochrome P-450 CYP2C19
IBA
09/2010 - 04/2009
3
Interleukin-8 (Interleukin 8)
IBA
02/2009 - 02/2005
3
Interleukin-6 (Interleukin 6)
IBA
02/2009 - 04/2007
3
Apolipoproteins
IBA
03/2008 - 11/2002
3
Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))
IBA
02/2008 - 01/2006
3
Peptide Hydrolases (Proteases)
FDA Link
02/2008 - 01/2005
3
Matrix Metalloproteinases (MMPs)
IBA
02/2008 - 01/2006
3
Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)
IBA
01/2008 - 12/2003
3
Technetium Tc 99m Sestamibi (Cardiolite)
FDA Link
Generic
03/2006 - 02/2004
3
Urokinase-Type Plasminogen Activator (Urokinase)
FDA Link
01/2006 - 11/2002
3
oxidized low density lipoprotein
IBA
10/2005 - 04/2005
3
Tissue Plasminogen Activator (Alteplase)
FDA Link
06/2004 - 03/2002
2
Fibrinogen (Factor I)
FDA Link
03/2013 - 04/2008
2
zotarolimus
IBA
01/2013 - 08/2011
2
Peroxidase (Myeloperoxidase)
IBA
04/2011 - 02/2008
2
Contrast Media
IBA
03/2011 - 01/2010
2
MB Form Creatine Kinase
IBA
11/2010 - 08/2008
2
Adenosine Diphosphate (ADP)
IBA
02/2010 - 07/2007
2
Potassium
IBA
11/2009 - 07/2004
2
Creatine Kinase (Creatine Phosphokinase)
IBA
04/2009 - 04/2008
2
Cholesterol
IBA
02/2009 - 07/2006
2
Interleukin-10 (Interleukin 10)
IBA
02/2009 - 11/2003
2
Cytokines
IBA
02/2009 - 02/2008
2
Phenobarbital (Luminal)
FDA Link
11/2008 - 08/2005
2
Peptides (Polypeptides)
IBA
04/2008 - 02/2008
Therapy/Procedure
83
Stents
05/2015 - 01/2000
65
Percutaneous Coronary Intervention
11/2013 - 01/2002
38
Therapeutics
09/2015 - 06/2002
27
Drug-Eluting Stents
11/2013 - 08/2004
3
Hematopoietic Stem Cell Mobilization
04/2008 - 03/2006
3
Catheter Ablation
06/2005 - 10/2002
3
Catheters
06/2003 - 10/2002
2
Aftercare (After-Treatment)
03/2010 - 10/2005
2
Electrodes (Electrode)
01/2010 - 03/2009